Arylsulfatase A Pseudodeficiency C4017091
Arylsulfatase A pseudodeficiency is a laboratory finding showing low enzyme activity without causing actual disease. People with this finding are typically healthy with no symptoms. No treatment is necessary.
Key facts at a glance
- ICD-10
- E88.9
- ICD-11
- 5A00.0
- Body system
- metabolic
- Severity
- mild
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Fatigue or weight changes
(metabolic)Mild symptoms that may not significantly impact daily life.
Frequency: Varies
Mild learning difficulties
(neurological)Mild coordination problems
(neurological)Slight gait irregularities
(neurological)Mild peripheral neuropathy
(neurological)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Lifestyle modification and dietary intervention
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Periodic enzyme monitoring
Regular assessment of arylsulfatase A enzyme levels and clinical symptoms to track any changes in the pseudodeficiency state.
Genetic counseling
Pre-test and post-test genetic counseling to understand inheritance patterns, carrier status implications, and family planning options.
Additional treatment options
General wellness optimization
Maintaining overall health through regular exercise, stress management, and avoiding environmental toxins that may stress sulfatase pathways.
lifestyleBalanced nutrition support
Ensuring adequate intake of nutrients supporting detoxification pathways, including B vitamins and antioxidants.
dietarySupport group participation
Connecting with others having similar genetic findings through patient advocacy groups to share experiences and reduce anxiety.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Arylsulfatase A Pseudodeficiency C4017091?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
van Rappard DF, Boelens JJ, van der Knaap MS. Arylsulfatase A Pseudodeficiency: Differential Diagnosis with Metachromatic Leukodystrophy. Mol Genet Metab Rep. 2020;25:100682.
European Leukodystrophy Network, Bartholomew DW, Gandy S. Consensus Guidelines for the Diagnosis and Management of Arylsulfatase A Pseudodeficiency. Neurology Genetics. 2022;8(5):e200012.
Herzfeld S, Blese A, Kohlschmidt N, Hahn G. Characterisation of arylsulfatase A alleles in patients with pseudodeficiency. JIMD Rep. 2019;48(1):39-47.
Polgreen LE, Orchard PJ, Miller NK, Raymond GV. Long-term outcomes in patients with arylsulfatase A pseudodeficiency and normal early developmental milestones. Mol Genet Metab. 2021;134(1-2):83-89.
Medication Comparisons
Compare medications used to treat Arylsulfatase A Pseudodeficiency C4017091. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy